Addressing the Biggest Challenges in Polymorphism

In this episode, a roundtable of distinguished guests discuss the impact and challenges of polymorphism. You’ll hear from these life science and pharmaceutical experts:- Eyal Barash, Life Sciences Patent Attorney and Founder at Barash Law- Steve Byrn, Professor and Dept. Head at Purdue University- Mansoor Khan, Professor and Vice Dean, Presidential Impact Fellow, Rangel College of Pharmacy, Texas A&M University- Ken Morris, University Professor, Director Lachman Institute for Pharmaceutical Analysis, Long Island University- Ann Newman, Solid-State and Pharmaceutical Consultant at Seventh Street Development Group- Raj Suryanarayanan, Professor and WIlliam and Mildred Peters Endowed Chair at University of MinnesotaWe talked about:- The guests’ backgrounds and origin stories in life science- The biggest challenges with respect to polymorphism- Thinking in terms of practical benefit vs. the clinical benefit- Distinguishing the formulation effect from the form effectThis episode is Part 1 of 2 on our polymorph roundtable discussion. Don’t miss the conclusion!For more insights into the pharmaceutical industry, subscribe to the show on Apple Podcasts, Spotify, or wherever podcasts are found.Listening on a desktop & can’t see the links? Just search for The Pharma Lab Show in your favorite podcast player.